Skip to content
A10107Assembly2023-2024 SessionSame asS7110

Stop PBM Underpaying Pharmacies

Official title

“Relates to reimbursements practices of pharmacy benefit managers”

Sponsor Anna KellesAD-125Affects Health
Status
In Assembly Committee
Health
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires pharmacy benefit managers to reimburse independent pharmacies at least as much as their affiliates for the same services.

Why it matters

  1. Levels the playing field for independent pharmacies. by requiring pharmacy benefit managers (PBMs) to pay independents at least as much as their own affiliated pharmacies, potentially supporting small businesses and local access to medications.

  2. Increases transparency and fairness in drug pricing. by forcing PBMs to justify reimbursement rates and adjust them if independent pharmacies cannot acquire drugs at or below the set maximum allowable cost, possibly reducing financial losses for independents.

  3. Could impact consumer access and pricing. by helping independent pharmacies stay in business, which may preserve or expand patient access to pharmacy services, especially in underserved or rural areas.

  4. May lead to scrutiny of PBM business practices. and encourage more regulatory oversight of how PBMs set and administer drug reimbursement rates, with possible ripple effects for insurance premiums and drug costs in the broader healthcare market.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Pharmacies and pharmacists

    The bill would require reimbursement at least equal to that paid to PBM affiliates for the same services and allow affected claims to be reversed and rebilled when specified drug-cost appeals require a pricing adjustment.

  • Pharmacy benefit managers

    PBMs denying reimbursement appeals would have to identify an equivalent drug available at the challenged price through the pharmacy’s primary wholesaler or adjust pricing above the pharmacy’s acquisition cost when the bill’s conditions are met.

  • PBM-affiliated pharmacies

    Their reimbursement rates would become the minimum benchmark for payments to other pharmacies for the same pharmacist services, calculated per unit using the same generic product identifier or generic code number.

Headline styles

Stop PBM Underpaying Pharmacies

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Anna Kelles

Assembly Member · Assembly District 125

No co-sponsors yet.

History

  1. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S7110Senate

Stop PBM Underpayments to Pharmacies

In Senate Committee · Health · Sponsor James Skoufis

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

10107

IN ASSEMBLY

May 3, 2024

Introduced by M. of A. KELLES -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to reimbursement rates of pharmacy benefit managers

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Paragraph (e) of subdivision 4 of section 280-a of the public health law, as added by chapter 828 of the laws of 2021, is amended and a new subdivision 4-a is added to read as follows:

(e) (i) if an appeal is denied, the pharmacy benefit manager shall identify the national drug code of a therapeutically equivalent drug, as determined by the federal Food and Drug Administration, that is available for purchase by pharmacies in this state from wholesalers registered pursuant to subdivision four of section sixty-eight hundred eight of the education law that the pharmacist or pharmacy purchases the majority of prescription drugs for resale from at a price which is equal to or less than the maximum allowable cost or other reimbursement pricing methodology used by the pharmacy benefits manager to determine cost for that drug as determined by the pharmacy benefit manager.

(ii) if the national drug code number provided by the pharmacy benefit manager is not available below the pharmacy acquisition cost from the pharmaceutical wholesaler from whom the pharmacy or pharmacist purchases the majority of prescription drugs for resale, then the pharmacy benefit manager shall adjust the maximum allowable cost or other pricing methodology used by the pharmacy benefits manager to determine cost above the challenging pharmacy's pharmacy acquisition cost and permit the pharmacy to reverse and rebill each claim affected by the inability to procure the drug at a cost that is equal to or less than the previously challenged maximum allowable cost.

4-a. Reimbursement. (a) A pharmacy benefit manager shall not reimburse a pharmacy or pharmacist in this state an amount less than the amount that the pharmacy benefit manager reimburses a pharmacy benefit manager affiliate for providing the same pharmacist services.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD05319-02-3

(b) The amount shall be calculated on a per unit basis based on the same generic product identified or generic code number.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.